APA (7th ed.) Citation

George, S., Carrico, J., Hicks, K. A., Loukov, D., Ng, C., & Curran, D. (2025). Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada. BMC Health Services Research, 25(1), 1. https://doi.org/10.1186/s12913-025-12550-x

Chicago Style (17th ed.) Citation

George, Sydney, Justin Carrico, Katherine A. Hicks, Dessi Loukov, Cheryl Ng, and Desmond Curran. "Cost-effectiveness and Public Health Impact of Recombinant Zoster Vaccine Versus No Herpes Zoster Vaccination in Selected Populations of Immunocompromised Adults in Canada." BMC Health Services Research 25, no. 1 (2025): 1. https://doi.org/10.1186/s12913-025-12550-x.

MLA (9th ed.) Citation

George, Sydney, et al. "Cost-effectiveness and Public Health Impact of Recombinant Zoster Vaccine Versus No Herpes Zoster Vaccination in Selected Populations of Immunocompromised Adults in Canada." BMC Health Services Research, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12913-025-12550-x.